# The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors

> **NCT01224509** · NA · TERMINATED · sponsor: **University of Southern California** · enrollment: 18 (actual)

## Conditions studied

- Cervical Prostaglandin EP3 Receptors
- Pregnancy

## Interventions

- **DRUG:** Mifepristone
- **OTHER:** Non-treatment

## Key facts

- **NCT ID:** NCT01224509
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Longer than expected recruitment period.
- **Last updated:** 2010-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01224509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01224509, "The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01224509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*